Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28.9M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
4.08M
-
Shares change
-
-319K
-
Total reported value, excl. options
-
$85.1M
-
Value change
-
-$6.8M
-
Number of buys
-
36
-
Number of sells
-
-21
-
Price
-
$20.80
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2021
68 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q3 2021.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.08M shares
of 28.9M outstanding shares and own 14.13% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (450K shares), Advisors Asset Management, Inc. (445K shares), MORGAN STANLEY (417K shares), WELLS FARGO & COMPANY/MN (344K shares), FLAGSHIP HARBOR ADVISORS, LLC (324K shares), LAZARD ASSET MANAGEMENT LLC (185K shares), LPL Financial LLC (147K shares), ADVISOR GROUP HOLDINGS, INC. (135K shares), COHEN & STEERS, INC. (126K shares), and Cetera Investment Advisers (119K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.